(Q42599779)

3 November 2017

1 reference

title

BRAF-inhibition and tumor immune suppression (English)

1 reference

3 November 2017

Shannon M Steinberg

1

1 reference

PMC publication ID

4404921

3 November 2017

Mary Jo Turk

series ordinal

2

1 reference

3 November 2017

1 February 2015

1 reference

3 November 2017

1 reference

3 November 2017

4

1 reference

3 November 2017

2

1 reference

3 November 2017

e988039

1 reference

Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

BRAF inhibition alleviates immune suppression in murine autochthonous melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4404921

10.4161/2162402X.2014.988039

16 August 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference

PMC publication ID

4404921

3 November 2017

PubMed publication ID

25949884

1 reference

PMC publication ID

4404921